Skip to main content
Explore URMC

Wilmot Cancer Institute Logo

menu
From AML to Ph.D.: How Wilmot helped one patient diagnosed with leukemia

From AML to Ph.D.: How Wilmot helped one patient diagnosed with leukemia

Ege Ozen was working toward his Ph.D. in Political Science when he was diagnosed with acute myeloid leukemia (AML). His oncology team at Wilmot and his wife have helped him through, and he achieved his goal of earning his Ph.D. in 2016. He's now a tenure-track professor at the College of Staten Island, CUNY. 

Four things to know about prostate cancer

Four things to know about prostate cancer

Prostate cancer is the most common cancer among men in the U.S. Each year, approximately 161,000 men in the U.S. are diagnosed with this type of cancer, including approximately 630 in Monroe County alone. Our prostate cancer specialists shared a few important facts everyone should know when it comes to prostate cancer.

Lymphoma: Targeting treatment for special populations

Lymphoma: Targeting treatment for special populations

Patrick Reagan, M.D., is working with Wilmot's Geriatric Oncology team, to develop a targeted approach for treating older adults with diffuse large B-cell lymphoma.

Lymphoma: Looking for Clues in the Immune System

Lymphoma: Looking for Clues in the Immune System

Wilmot researchers are studying the non-cancer cells in a tumor — known as the tumor microenvironment — to learn more about the important role they play in the course of lymphoma.

Sun protection is crucial during, after treatment

Sun protection is crucial during, after treatment

Chemotherapy and radiation can increase your sensitivity to the sun, putting you at risk for burns. Even if you’re not sunbathing, it’s important to take precautions any time you’ll be outside.